Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications - Quiz - MDSpire

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

  • By

  • İlkay Çıtakkul

  • Yasemin Bakkal Temi

  • Ece Baydar

  • Elif Şahin

  • Umut Kefeli

  • Devrim Çabuk

  • Kazım Uygun

  • May 29, 2026

  • 0 min

Share

Original Source(s)

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications

  • by İlkay Çıtakkul, Yasemin Bakkal Temi, Ece Baydar, Elif Şahin, Umut Kefeli, Devrim Çabuk, Kazım Uygun

  • May 29, 2026

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort